Exact Mass: 477.1711334

Exact Mass Matches: 477.1711334

Found 500 metabolites which its exact mass value is equals to given mass value 477.1711334, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CB3717

10-Propargyl-5,8-dideazafolic acid

C24H23N5O6 (477.1648258)

D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents

19-Chloroproansamitocin

C25H32ClNO6 (477.19180420000004)

Furcelleran

3-Benzyl 5-ethyl 6-methyl-2-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylic acid

C31H27NO4 (477.19399820000007)

Furcelleran is an emulsifier, stabiliser, thickening agent. Furcelleran salts prepd. by increasing the concentration of the naturally occurring cations (ammonium, calcium, potassium or sodium) have similar utility. Emulsifier, stabiliser, thickening agent. Furcelleran salts prepd. by increasing the concentration of the naturally occurring cations (ammonium, calcium, potassium or sodium) have similar utility

(2S,3R)-2-(4-{2-[(3S,4S)-3,4-Dimethylpyrrolidin-1-YL]ethoxy}phenyl)-3-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL

C28H31NO4S (477.19736860000006)

10-Propargyl-5,8-dideazafolic acid

2-[(4-{[(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}phenyl)formamido]pentanedioic acid

C24H23N5O6 (477.1648258)

4-(7-(((1R)-1-((3-Chloro-2-thienyl)methyl)propyl)amino)-3H-imidazo(4,5-b)pyridin-3-yl)-N-ethyl-2,3-dihydroxycyclopentanecarboxamide, (1S,2R,3S,4R)-

C22H28ClN5O3S (477.16012880000005)

Isopropyl 4-(1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)piperidine-1-carboxylate

Isopropyl 4-(1-(2-fluoro-4-(methylsulphonyl)phenyl)-1H-pyrazolo[3,4-D]pyrimidin-4-yloxy)piperidine-1-carboxylic acid

C21H24FN5O5S (477.1482106)

Batimastat

2-[1-(Dihydroxycarbonimidoyl)-2-(thiophen-2-ylsulphanyl)ethyl]-4-methyl-N-[1-(methyl-C-hydroxycarbonimidoyl)-2-phenylethyl]pentanimidic acid

C23H31N3O4S2 (477.1755886)

5-O-Benzyl 3-O-ethyl 2-methyl-6-phenyl-4-(2-phenylethynyl)-3,4-dihydropyridine-3,5-dicarboxylate

5-O-Benzyl 3-O-ethyl 2-methyl-6-phenyl-4-(2-phenylethynyl)-3,4-dihydropyridine-3,5-dicarboxylic acid

C31H27NO4 (477.19399820000007)

Pralatrexate

2-({4-[1-(4-amino-2-imino-2,3-dihydropteridin-6-yl)pent-4-yn-2-yl]phenyl}formamido)pentanedioate

C23H23N7O5 (477.1760588)

ritanserin

6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

C27H25F2N3OS (477.1686304)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].

(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide

N-({1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl}methyl)-1-benzofuran-4-carboximidate

C26H24FN3O3S (477.15223260000005)

7-hydroxy-1-(3,4-dihydroxy)-N2,N3-bis(4-hydroxyphenethyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxamide

C27H27NO7 (477.17874320000004)

Pralatrexate

Pralatrexate(Folotyn)

C23H23N7O5 (477.1760588)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor

Ser Gln Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-carboxypropanamido]pentanedioic acid

C17H27N5O11 (477.17069919999994)

Ala Gly Asp Glu Ser

C17H27N5O11 (477.17069919999994)

ritanserin

C27H25F2N3OS (477.1686304)

Ala Cys Glu Arg

(4S)-4-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}butanoic acid

C17H31N7O7S (477.2005576)

Ala Cys Arg Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C17H31N7O7S (477.2005576)

Ala Asp Ser Trp

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C21H27N5O8 (477.1859542)

Ala Asp Trp Ser

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C21H27N5O8 (477.1859542)

Ala Glu Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H31N7O7S (477.2005576)

Ala Glu Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid